Jefferies initiates analytical coverage of Celon Pharma

Jefferies initiates analytical coverage of Celon Pharma, with the recommendation: Buy and the target price of PLN 37.50. The report is available to Jefferies customers.

Lucy Codrington, MBChB | Equity Analyst, European Healthcare
Jefferies International Ltd | 100 Bishopsgate | London | EC2N 4JL |
[email protected]